Tech Company Financing Transactions

Goldfinch Bio Funding Round

Goldfinch Bio, based in Cambridge, raised $100 million in funding from Eventide Asset Management, Ally Bridge Group and BlackRock.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from the Series B financing will enable the advancement of GFB-887 and GFB-024 through three potential clinical proof-of-concept readouts -- in FSGS and DN and in CB1-mediated DN, respectively -- and will also support continued development of the Company's discovery platform and preclinical pipeline.

Company Information

Company Status
Private & Independent
Mailing Address
215 First St. 4th Floor
Cambridge, MA 02142
Email Address
At Goldfinch, we are pioneering a new approach to discover and develop therapeutics for kidney disease that is unprecedented.
Goldfinch Bio LinkedIn Company Profile
Social Media
Goldfinch Bio Company Twitter Account
Company News
Goldfinch Bio News
Goldfinch Bio on Facebook
Goldfinch Bio on YouTube

Management Team

Email & Social
Chief Executive Officer
Anthony Johnson
  Anthony Johnson LinkedIn Profile  Anthony Johnson Twitter Account  Anthony Johnson News  Anthony Johnson on Facebook
Chief Financial Officer
Kyle Kuvalanka
  Kyle Kuvalanka LinkedIn Profile  Kyle Kuvalanka Twitter Account  Kyle Kuvalanka News  Kyle Kuvalanka on Facebook
Chief Medical Officer
Frank Czerwiec
  Frank Czerwiec LinkedIn Profile  Frank Czerwiec Twitter Account  Frank Czerwiec News  Frank Czerwiec on Facebook
VP - Bus. Development
Lori Rudolph-Owen
  Lori Rudolph-Owen LinkedIn Profile  Lori Rudolph-Owen Twitter Account  Lori Rudolph-Owen News  Lori Rudolph-Owen on Facebook
VP - Human Resources
Curtis Demick
  Curtis Demick LinkedIn Profile  Curtis Demick Twitter Account  Curtis Demick News  Curtis Demick on Facebook
VP - R & D
Jean-Christophe Harmange
  Jean-Christophe Harmange LinkedIn Profile  Jean-Christophe Harmange Twitter Account  Jean-Christophe Harmange News  Jean-Christophe Harmange on Facebook



Browse more venture capital transactions:

Prev: 7/1/2020: Aclaimant venture capital transaction
Next: 7/1/2020: Capital venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary